<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 對(duì)照品 > 自制對(duì)照品 >
    Everolimus, Cyclosporine and Tacrolimus Mix Standard
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):E608165
    產(chǎn)品名稱(chēng):Everolimus, Cyclosporine and Tacrolimus Mix Standard
    產(chǎn)品CAS:
    規(guī)格含量:25mg
    產(chǎn)品價(jià)格:面議
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹
    標(biāo)準(zhǔn)品編號(hào): E608165
    名稱(chēng): Everolimus, Cyclosporine and Tacrolimus Mix Standard
    分子式: C??H??NO?? • C??H???N??O?? • C??H??N
    分子量: 958.2212026
    種類(lèi): Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
    應(yīng)用: Everolimus (E945400) is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation. Cyclosporine(C990065) is an immunopsupressent thought to bind to cyclophilin in T-lymphocytes. Tacrolimus (F370000) is also an immunosuppressant that blocks T-cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release.
    參考文獻(xiàn)


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      亚洲精品无码午夜福中文字幕 | 免费黄色小说在线观看 | 夜夜操狠狠操 | 欧美成人片网址 | 日韩色偷偷 |